Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer: A Multicenter, Retrospective Study.

Abstract

Authors

• Yuming Jiang
  Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
• Cheng Jin
  Department of Pathology, Hangzhou Women's Hospital, Hangzhou, 310008, Zhejiang, China.
• Heng Yu
• Jia Wu
• Chuanli Chen
  Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
• Qingyu Yuan
  Nanfang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
• Weicai Huang
  Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
• Yanfeng Hu
  Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
• Yikai Xu
• Zhiwei Zhou
  Interdisciplinary Research Center on Biology and Chemistry, and Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China.
• George A Fisher
  Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, California.
• Guoxin Li
  Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. gzliguoxin@163.com caishirong@yeah.net ehbhltj@hotmail.com keekee77@126.com.
• Ruijiang Li
  Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education (GI-CoRE), Proton Beam Therapy Center, North 14 West 5 Kita-ku, Sapporo, Hokkaido, 060-8648, Japan.

Keywords

External Resources